Camurus AB

Camurus AB
Stock Exchange OTC Publication Venue
EPS
SEK6.28
Market Cap
SEK3.53 B
Shares Outstanding
47.98 M
Public Float
15.74 M

Profile

Address
Ideon Science Park
Lund SN 223 70
Sweden
Employees -
Website http://www.camurus.com
Updated 07/08/2019
Camurus AB engages in the research, development, and commercialization of specialty medicines. It provides its products for the treatment of severe and chronic conditions, which includes opioid dependence, pain, cancer, and endocrine disorders. The company was founded by Kare Larsson in 1991 and is headquartered in Lund, Sweden.

Financials

View All

Sven Fredrik Tiberg
President, Chief Executive Officer & Director
Folke Per-Olof Wallström
Chairman